Antitumor Activity of BIBF 1120, a Triple Angiokinase Inhibitor, and Use of VEGFR2+pTyr+ Peripheral Blood Leukocytes as a Pharmacodynamic Biomarker in Vivo

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-09-2755
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

BIBF 1120/Nintedanib: A New Triple Angiokinase Inhibitor-Directed Therapy in Patients With Non-Small Cell Lung Cancer

Expert Opinion on Investigational Drugs
MedicinePharmacology
2013English

BIBF 1120 (Nintedanib), a Triple Angiokinase Inhibitor, Induces Hypoxia but Not EMT and Blocks Progression of Preclinical Models of Lung and Pancreatic Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

SKLB-287, a Novel Oral Multikinase Inhibitor of EGFR and VEGFR2, Exhibits Potent Antitumor Activity in LoVo Colorectal Tumor Model

Neoplasma
Cancer Research
2014English

In Vivo Imaging as a Pharmacodynamic Marker

Clinical Cancer Research
Cancer ResearchOncology
2014English

Peripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis

PLoS ONE
Multidisciplinary
2012English

In Vivo Monitoring of Fetoplacental Vegfr2 Gene Activity in a Murine Pregnancy Model Using a Vegfr2-Luc Reporter Gene and Bioluminescent Imaging

Reproductive Biology and Endocrinology
GynecologyEndocrinologyReproductive MedicineDevelopmental BiologyObstetrics
2011English

hTERT Promoter Methylation Status in Peripheral Blood Leukocytes as a Molecular Marker of Head and Neck Cancer Progression

Journal of Applied Genetics
MedicineGenetics
2018English

P3.15-008 [F18]PARPi PET as an in Vivo Pharmacodynamic Biomarker of PARP Inhibitor Therapy in Patient-Derived Xenografts of Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

In Vivo Pharmacodynamic Activity of the Glycopeptide Dalbavancin

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy